U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06944925) titled 'A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD)' on April 18.

Brief Summary: This study is a randomized, blinded, placebo-controlled single (SAD) and multiple ascending dose (MAD) study to evaluate the safety, tolerability, pharmacokinetics, immunogenicity, pharmacodynamics and exploratory clinical activity of BBT002 in healthy volunteers (HVs) and in adult patients with Chronic Obstructive Pulmonary Disease (COPD).

Study Start Date: May 08

Study Type: INTERVENTIONAL

Condition: Chronic Obstructive Pulmonary Disease

Intervention: DRUG: BBT002

BBT002 will be...